Found 62 presentations matching your search
Significantly lower rate of mean annual eGFR decline with semaglutide compared with placebo in the o...
Semaglutide
Oral semaglutide to reduce cardiovascular event
SEMA START - SEMAglutide Scientific TAlkshow with expeRTs
Cagrisema(Cagrilintide/Semaglutide) is a combination of cagrilintide (a dual amylin and calcitonin r...
Semaglutide once weekly improve renal impairment in DKD
Managing Type 2 diabetes isn’t just about numbers — it’s about building sustainable habits, em...
OBESITY MANAGEMENT
AGONISTAS RECEPTOR GLP1,ACTUALIZACIÓN,ENZAYOS CLINICOS
Obesity is the latest pandemic engulfing the whole world. Here we present the relationship of obesit...
Ponencia en el SEMFYC "Nuevas Recomendaciones en Diabetes tipo 2: algoritmo ADA/EASD 2019"...
Ppt
Diabetes mellitus
anesthesia consideration in patient scheduled to OR with history of chronic medication GLP-1RAs
newer antidiabetics drugs
journal presentation
management of obesity in pediatrics
Recent advances in antiobesity drugs
American Gastroenterology association obesity update
sudden deathn in young
Anti diabetic drugs
Role of forensic medicine and forensic pathologist in cases of medicolegal aspects of unapproved use...
Cardiovascular disease.
This lecture was part of a vertical integration program for the Department of Pharmacology prepared ...
![GLP-1RAs-and-Anesthesia-A-Guide-to-Safe-Practices [Autosaved].pptx](https://slidepub.com/thumb/6278/283886278.jpg)
